Conservatively managed patients with non-ST-segment elevation acute coronary syndrome are undertreated with indicated medicines.
Elena CandelaFrancisco MarínJose Miguel Rivera-CaravacaNuria Vicente IbarraLuna CarrilloMaría Asunción Esteve-PastorTeresa LozanoManuel Jesús MacíasVicente PerniasMiriam SandínEsteban Orenes-PiñeroMiriam Quintana-GinerIgnacio HortelanoBeatriz VillamíaAndrea VelizMariano ValdésJuan Gabriel Martínez-MartínezJuan Miguel Ruiz-NodarPublished in: PloS one (2018)
Despite current invasive management of NSTE-ACS, patients not receiving catheterization are at very high risk for under treatment with recommended drugs, including NADs. Their medium-term prognosis is poor, with high mortality. Patients treated with PCI receive better pharmacological management, with high use of NADs.
Keyphrases
- acute coronary syndrome
- percutaneous coronary intervention
- antiplatelet therapy
- end stage renal disease
- ejection fraction
- newly diagnosed
- prognostic factors
- preterm infants
- heart failure
- acute myocardial infarction
- coronary artery disease
- st segment elevation myocardial infarction
- risk factors
- cardiovascular events
- atrial fibrillation
- gestational age
- left ventricular
- drug induced